Cite
HARVARD Citation
Wu, S. et al. (2021). A genomic instability-derived risk index predicts clinical outcome and immunotherapy response for clear cell renal cell carcinoma. Bioengineered. 12 (1), pp. 1642-1662. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wu, S. et al. (2021). A genomic instability-derived risk index predicts clinical outcome and immunotherapy response for clear cell renal cell carcinoma. Bioengineered. 12 (1), pp. 1642-1662. [Online].